Status:
COMPLETED
A Pilot Study Examining a Reinforcement Approach to Improve Diabetes Management
Lead Sponsor:
UConn Health
Collaborating Sponsors:
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
15-21 years
Phase:
NA
Brief Summary
Glucose control is necessary to avoid the immediate and long-term adverse effects associated with type 1 diabetes, and frequent self-monitoring of blood glucose is the first important step to achievin...
Eligibility Criteria
Inclusion
- age 15-21 years old
- diagnosis of type 1 diabetes (T1D) \>12 months via ADA guidelines (Silverstein et al., 2005)
- average A1c \>7.5% and \<11% during the year before study entry, and most recent A1c \>7.5% but \<11%
- SMBG user with clinical recommendations to test \>4 times/day
- past month SMBG \<4 times/ day on average
- English speaking and able to read at \>5th grade level
Exclusion
- have a major psychiatric or neurocognitive disorder that would inhibit participation
- have a major visual impairment
- meet DSM-IV criteria for pathological gambling
- have a significant other medical condition that impacts diabetes management
- plan to switch insulin delivery mode (injection to pump or vice versa) in the next 12 months, or have recently switched
- are pregnant or trying to become pregnant
- are participating in another clinical trial
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01829555
Start Date
February 1 2013
End Date
August 1 2014
Last Update
November 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Endocrinology, Yale University
New Haven, Connecticut, United States, 06519